Clinical Trial Results:
            "Estudio de fase 2, aleatorizado y abierto, de bosutinib administrado en combinación con exemestano frente a exemestano solo como tratamiento de segunda línea en mujeres posmenopáusicas con cáncer de mama RE+/RPg+/ErbB2- localmente avanzado o metastático"
    
|     Summary | |
|     EudraCT number | 2008-002457-20 | 
|     Trial protocol | ES BE NL FR GB | 
|     Global completion date | 
                                    31 May 2010
                             | 
|     Paediatric regulatory details | |
|     Is the trial part of an agreed EMA paediatric investigation plan? | 
                                        No
                                 | 
|     Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Results information | |
|     Results version number | v1(current) | 
|     This version publication date | 
                                    21 Mar 2016
                             | 
|     First version publication date | 
                                    11 Feb 2015
                             | 
|     Other versions | |
|     Summary report(s) | 3160A6-2207 | 
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.    
 
				
